Skip to main content
. 2018 Oct 23;11:2551–2560. doi: 10.2147/JPR.S147199

Table 1.

FM classes

Class Description Demographics: sex, %; age, mean (SD) Main comorbidities Body region prominence Main secondary conditions Main treatment focus
1. With three subclasses Regional FM with classic symptoms 77.9% females, 55.3 (16.5) years; 22.1% males, 55.4 (16.5) years Interstitial cystitis, muscle spasm, spinal arthritis Knee, cervical, shoulder, arm, chest GERD, osteoporosis, RLS Facets and spinal cord stimulators
2. With two subclasses Generalized FM with increasing widespread pain and additional symptoms 81.6% females, 61.4 (17.3) years; 18.4% males, 58.9 (17.2) years Arthritis, upper Chest, lumbar/hip, and significant increase in knee GERD, RLS, polio Epidurals, facets, spinal cord stimulators, bursa/trigger point injections, cervical/thoracic injections
3. With three subclasses Advanced FM with associated conditions, increasing widespread pain, increased sleep disturbance, and chemical sensitivity 74.2% females, 59.8 (18.0) years; 25.8% males, 61.4 (21.4) years Arthritis, upper body/limb pain, cervical conditions, migraine Chest, lumbar/hip, and significant increase in knee GERD, RLS, polio Epidurals, facets, spinal cord stimulators, bursa/trigger point injections, cervical/thoracic injections
4. With no subclasses Secondary FM reactive to disease 80.5% females; 61.3 (17.8) years; 19.5% males, 49.4 (17.0) years Chronic pain syndrome, joint/limb pain Chest MS, lupus, TMJ, IBS Joint and bursa injections

Abbreviations: FM, fibromyalgia; GERD, gastroesophageal reflux disease; IBS, irritable bowel syndrome; MS, multiple sclerosis; TMJ, temporomandibular joint disorder; RLS, restless leg syndrome.